NUSCAN

diagnostic assays and reagents for clinical and medical use, namely for the testing of body fluids; diagnostic chemical, biochemical and biological preparations for medical purposes, namely for treating and preventing cancers and other clinical pathologies; diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely cancers

testing instruments for medical diagnostic purposes, namely, instruments for medical diagnostic testing in the field of cancer; medical devices, namely, automated medical diagnostic image analyzers featuring a system consisting of computer hardware as a component of the medical devices, for use in detecting epigenetic signatures in the field of clinical pathology; diagnostic testing kits consisting primarily of probes, buffer, and reagent for use in microbial testing

medical testing and diagnostic services, namely, testing for medical diagnostic or treatment purposes in the field of cancer, autoimmune disease, maternal fetal medicine; clinical pathology services, namely, medical testing for diagnostic or treatment purposes in the field of clinical pathology; medical analysis services for diagnostic and treatment purposes relating to the treatment of persons; medical testing for diagnostic or treatment purposes in the field of pathology relating to the treatment of persons; medical diagnostic testing, monitoring and reporting services